Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

169.44 +2.10 (+1.25%)

Streaming Delayed Price Updated: 11:17 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Fresh Look At Long Bonds ↗

September 14, 2023

As long as the S&P 500 outperforms long bonds (TLT) risk is on.

Via Talk Markets

Topics Bonds Stocks

Healthcare Playbook Revisited - Growth Plus Value ↗

September 13, 2023

Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on.

Via Talk Markets

Time For Gilead Sciences-Heavy ETFs? ↗

September 12, 2023

Gilead Sciences has underperformed the broader market this year by a hefty margin.

Via Talk Markets

Technical Correction Or Return Of The Bear Market? ↗

September 06, 2023

The QQQ chart right now has a few key aspects.

Via Talk Markets

It’s Really All About the Retail Sector Now ↗

September 05, 2023

Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low.

Via Talk Markets

Three Lessons For Investing In Biotech Companies ↗

August 23, 2023

Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted.

Via Talk Markets

3 Top ETFs to Buy Right Now ↗

July 24, 2023

These three exchange-traded funds could be winning plays for patient investors.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy Now: September 2023 ↗

September 04, 2023

With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize.

Via InvestorPlace

Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed ↗

August 31, 2023

Via Benzinga

Topics ETFs

Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗

August 30, 2023

It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months.

Via Talk Markets

Topics ETFs

BRICS And The Recent Headline ↗

August 23, 2023

At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west.

Via Talk Markets

The US Dollar And Long Bonds Doing The Dosey Doe ↗

August 22, 2023

With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds.

Via Talk Markets

5 Meme Stocks to Sell Immediately, According to AI ↗

August 22, 2023

As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.

Via InvestorPlace

Topics Artificial Intelligence

Biotechnology On Drugs ↗

August 21, 2023

Biotechnology has traded basically sideways since the start of 2023.

Via Talk Markets

Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner ↗

August 21, 2023

Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.

Via Talk Markets

3 Strong Biotech Performers To Watch As Sector Nears Breakout

August 17, 2023

As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming.

Via MarketBeat

Topics ETFs

The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗

August 17, 2023

This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.

Via InvestorPlace

Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP ↗

August 12, 2023

Via Benzinga

CPI-Market Impact Now And Later? ↗

August 10, 2023

A discussion about inflation, bonds, calendar ranges, and places to park your money

Via Talk Markets

Topics Bonds Economy

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗

August 10, 2023

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.

Via Benzinga

Topics ETFs Economy

5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023 ↗

August 08, 2023

These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth.

Via The Motley Fool

Rising Stars, Falling Trends: July's Industry ETF Winners And Losers ↗

July 31, 2023

Via Benzinga

The July 6-Month Calendar Range SPY QQQ IWM TLT ↗

July 26, 2023

Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode.

Via Talk Markets

Now That The July 6-Month Calendar Range Is Set ↗

July 24, 2023

As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps.

Via Talk Markets

On A Winning Streak! Many Market Signs Appear More Bullish ↗

July 23, 2023

This past week corporate earnings announcements picked up speed. You may recall that we mentioned the large money center Banks had announced the week before. If you did not read last week’s issue, you...

Via Talk Markets

Major Sector ETFs Re-Set In July-Blueprint ↗

July 17, 2023

Retail XRT is in a Distribution phase and has to clear the 200-WMA and calendar range high at 67.42. A move under 63.40 would be weak.

Via Talk Markets

Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗

July 17, 2023

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

Via Talk Markets

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

Moderna: Declining Performance And Relative Weakness

June 30, 2023

Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal.

Via MarketBeat

Topics ETFs

Biotech And Healthcare Stocks Lagging ↗

June 21, 2023

Healthcare is a laggard with XLV down YTD but UNH is still a core position.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.